SlideShare a Scribd company logo
Live Webinar
on
FDA Inspection
Readiness – Preparing
for an Inspection
Name of the Presenter.
Charles H Paul, President
C. H. Paul Consulting, Inc.
Topics
2
◼ The mechanics of the readiness process, auditing – who gets audited,
frequency of audits, and the inspection process explained
◼ Types of inspections and their implications
◼ The heart of compliance – doing the right things right
◼ Selecting your subject matter experts
◼ Training your SME’s – what do they need to know and how do you train
◼ Inspection preparedness – what to expect and how to prepare
◼ The readiness inspection from the auditor’s perspective
◼ Responding/interacting with the inspection team – inspection behavior –
how to act – what to say and what not to say
Who does the FDA Inspect?
◼ Federal Food, Drug, and Cosmetics (FD&C) Act, domestic drug
establishments, and Class II and Class III device manufacturers inspected
every two years
◼ Foreign manufacturers
◼ Inspections conducted based on risk
◼ Higher-risk products more likely to be audited
◼ Facilities having historically significant violations
◼ Inspection focus
 Quality and Product Safety
 Facility
 Process
 Data
3
Purpose of Inspections
4
• Compliance with FDA regulations
• Product development
• Quality System (QS) and manufacturing practices
• Controls are in-place and they are effective
• Recalls, enforcement actions, complaints, significant
adverse event reports, surveillance
• Ensure consumer protection
Types of Inspections
5
◼ Pre-Approval Inspections (PAI Post-Approval Inspections
◼ Surveillance Inspections
◼ For-Cause or Triggered Inspections
◼ Compliance Follow-Up Inspections
◼ Foreign Inspections
◼ Focused Inspections
◼ Risk-Based Inspections
◼ Follow-Up or Recurrent Inspections
◼ Adverse Event Inspections
◼ Import Inspections
◼ Bioequivalence and Bioavailability Inspections
Types of Inspections
◼ Pre-Approval Inspections
◼ Post Approval Audit Inspections
◼ Drug Manufacturing Inspections
6
Pre-Approval Inspections
7
◼ FDA approves New Drug Applications, Abbreviated New
Drug Applications, Biologic Licensing Applications
◼ Assure that controls for manufacture, processing,
packing, and testing are adequate
◼ Pre-approval inspection performed to ensure that
manufacturer can manufacture the drug.
Post Approval Audit Inspections
8
◼ Designed to audit for changes in the production and
control practices that occur after approval
◼ Post Approval Audit Inspections confirm that
commitments have been completed or are underway
Drug Manufacturing Inspections
9
To determine whether inspected firms
are operating in compliance with
applicable cGMP requirements
Best Practices – “Do the right Things Right”
10
◼ Preparation
• Have adequately trained staff with relevant expertise and accountability.
• Obtain upper management support
• Utilize and value independent regulatory compliance and quality assurance
teams
• Ensure the commitments made from previous inspections have been
implemented
• Understand your potential quality data sources so information can be quickly
and easily sourced as required
• Implement and assess an effective quality system
• Ensure there is a designated company Inspection Team
• Ensure all proper documentation and records are up-to-date
• Maintain effective Management Review and CAPA systems.
• Identify true root causes of issues using appropriate problem-solving tools.
• Understand when a product, or quality issue is significant.
• Have defined metric systems to monitor your quality system in order to identify
trends, gaps, and opportunities
Inspection Process Overview
11
❑ Alert system activated
❑ Company Inspection Team members assemble
❑ FDA provides the company with Form 482
❑ FDA will explain why they are at your site
❑ FDA provided with a facility tour
❑ FDA inspection team, will request the documents they
need
❑ FDA will conduct the Exit Inspection Meeting.
❑ FDA findings are reviewed
Post Inspection
• Date of inspection
• Inspection team members
• Reasons for response
• Response to each cited deficiency
• Description of preventive and corrective action
• Items still in dispute
12
Post Inspection
13
◼ If the inspection has an Official Action
Indicated classification, FDA send a
warning letter
◼ Company will need to reply
◼ FDA conducts a follow-up inspection
◼ FDA may issue a close-out letter
Why are SME’s Indispensable to the Organization?
14
◼ Expertise in Specific Areas
◼ Demonstrating Compliance
◼ Preparing Documentation
◼ Training and Coaching Staff
◼ Addressing Non-Compliance Issues
◼ Facilitating Communication
◼ Ensuring Ongoing Compliance
Who are SMEs?
15
◼ Quality Assurance (QA) and Quality Control (QC) Experts
◼ Regulatory Affairs Specialists
◼ Manufacturing and Process Engineers
◼ Microbiologists and Chemists
◼ Clinical Research Professionals
◼ Pharmacovigilance Experts
◼ Labeling and Packaging Specialists
◼ Validation Experts
◼ Food Safety and HACCP Experts
◼ Clinical Laboratory Directors
◼ Environmental Health and Safety Specialists
◼ Documentation and Records Management Experts
Why is Proper SME Selection Important to the FDA
Inspection?
44
◼ Accuracy and Credibility
◼ Regulatory Understanding
◼ Effective Communication
◼ Smooth Inspection Process
◼ Confidence and Professionalism
◼ Problem-Solving Abilities
◼ Representation of Expertise
◼ Mitigating Risks
◼ Resource Efficiency
◼ Long-Term Impact
◼ Employee Morale
◼ Organizational Preparedness
Selecting SMEs
17
◼ Identify Relevant Areas
◼ Define SME Criteria
◼ Cross-Functional Representation
◼ Regulatory Knowledge
◼ Communication Skills
◼ Experience with Inspections
◼ Problem-Solving Abilities
◼ Preparation and Training
◼ Calm Under Pressure
◼ Collaborative Attitude
◼ Post-Inspection Feedback
Preparing SME’s
18
◼ Provide In-Depth Regulatory Training
◼ Review Inspection Process and Expectations
◼ Mock Inspection Workshops
◼ Communication Skills Training
◼ Prepare Documentation
◼ Familiarize with Facility Layout
◼ Prepare for Questions
◼ Confidence Building
◼ Team Collaboration
◼ Role-Playing Scenarios
◼ Post-Preparation Feedback
Doing the Right Thing
◼ Always be professional
◼ Be dressed properly – neat and clean
◼ Follow all company cleanliness, movement, and
dressing requirements
◼ Be courteous and polite at all times
◼ Correct all errors and miscommunications when
discovered as soon as possible
19
What a Successful FDA Audit Looks Like
20
◼ Compliance with Regulations
◼ Public Health and Safety
◼ Market Confidence
◼ Continued Market Access
◼ Operational Improvements
◼ Reduced Legal and Financial Risk
◼ Enhanced Consumer Trust
◼ Facilitates Innovations
◼ Employee Morale and Engagement
◼ Educational Opportunity
Tips for Doing it Right
21
◼ Understand the Scope and Standards
◼ Maintain Compliance at All Times
◼ Conduct Regular Internal Audits
◼ Prepare Your Team
◼ Organize Documentation
◼ Review Past Inspections
◼ Mock Inspections
◼ Improve Communication Skills
◼ Ensure Facility Readiness
◼ Stay Informed About Industry Changes
◼ Legal and Expert Consultation
◼ Handle Issues Professionally
Review
22
◼ Always be prepared by doing the right things right
◼ Always maintain a compliant GMP environment
◼ Have effective and accessible compliance documentation
◼ Have a plan for how you will manage your inspection
◼ Be professional during an inspection
◼ Demonstrate proper body language
◼ Be timely in providing the documents and samples requested
◼ Control the flow of communication
◼ Properly answer questions
◼ Respond to findings thoroughly and in a timely manner
Questions
69
Register Now

More Related Content

PDF
PDF
3-Hour FDA Audit Preparation Virtual Seminar
PPTX
Focus on FDA cGMPs inspections
PPT
Leadership For The FDA Inspection The Manager Review
PDF
FDA PreApproval Inspection - Part 2
PDF
FDA PreApproval Inspection - Part 1
PPTX
Inspection Readiness, Inspection readiness for clinical trial site..pptx
PPTX
FDA inspection of manufacturing sites
3-Hour FDA Audit Preparation Virtual Seminar
Focus on FDA cGMPs inspections
Leadership For The FDA Inspection The Manager Review
FDA PreApproval Inspection - Part 2
FDA PreApproval Inspection - Part 1
Inspection Readiness, Inspection readiness for clinical trial site..pptx
FDA inspection of manufacturing sites

Similar to FDA Best Audit Practices – Get Ready For The Inspection That Is Coming (20)

PPTX
FDA Inspection Readiness.pptx
PDF
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
PPTX
FDA audit series part 1, Preparing for the Audit
PPT
Fda Inspection
PDF
Presentation on Overview of Drug Manufacturing inspections.pdf
PDF
Preparing and handling an inspection
PDF
Fda validation inspections
PDF
Fda validation inspections
DOCX
What to Expect During an FDA Inspection?
PPTX
Simple ways to prepare for an FDA audit
PPTX
The FDA just called, Now What?
PPTX
How To Make Your FDA Audit or FDA Inspection A Success?
PDF
Drug regulatory affairs D2S06-Raghavachari-508.pdf
PPTX
Product life cycle management
PPTX
Preparing for your next FDA Inspection D3.pptx
PDF
FDA Inspections - Lessons Learnt
DOCX
Preparing for fda
PPTX
Process Validation for Beginners - FDA - EMA Approach
PDF
Handling of a fda inspection [compatibility mode]
PPTX
Drug product inspection & change control
FDA Inspection Readiness.pptx
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
FDA audit series part 1, Preparing for the Audit
Fda Inspection
Presentation on Overview of Drug Manufacturing inspections.pdf
Preparing and handling an inspection
Fda validation inspections
Fda validation inspections
What to Expect During an FDA Inspection?
Simple ways to prepare for an FDA audit
The FDA just called, Now What?
How To Make Your FDA Audit or FDA Inspection A Success?
Drug regulatory affairs D2S06-Raghavachari-508.pdf
Product life cycle management
Preparing for your next FDA Inspection D3.pptx
FDA Inspections - Lessons Learnt
Preparing for fda
Process Validation for Beginners - FDA - EMA Approach
Handling of a fda inspection [compatibility mode]
Drug product inspection & change control
Ad

More from Conference Panel (20)

PDF
Upcoming New 2025 HIPAA Changes and Beyond
PDF
HIPAA and the New Rules Regarding Reproductive Health Care
PDF
Prepare for the 2025 ICD-10-CM Code Updates
PDF
21 CFR Part 11 Electronic Records and Signatures FDA Compliance
PDF
USDA Final Genetically Modified Organism (GMO) Label Rule
PDF
Chronic Care Management What do you need to know to Design and Implement Succ...
PDF
Master CMS Medicare PECOS 2.0: New Enrollment and Validation Portal 2024
PDF
Corrective and Preventive Action (CAPA): Our Most Important Quality Process
PDF
G2211 and New 2024 Billing Opportunities
PDF
Understand and Apply ISO New Climate Change Requirements
PDF
Navigating Most Problematic CMS Standards - Hospital Restraint and Seclusion
PDF
DEI at the Hospital - Addressing Bias in Medical Staff Credentialing and Peer...
PDF
2024 HIPAA Compliance Training Guide to the Compliance Officers
PDF
Medicare and Medicaid Managed Care Enrollments in 2024
PDF
Dispelling HIPAA Myths: Texting, Emailing, and BYOD Best Practices
PDF
Medical Record Chapter: Meeting the CMS Hospital CoPs and Access Requirements
PDF
Grievances and Complaints 2024 Compliance with the CMS CoPs, Joint Commission...
PDF
The 2024 Prior Authorization Process For Medical Providers
PDF
Protecting Patient Privacy: Navigating HIPAA in Digital Landscapes
PDF
HIPAA Guidelines and Electronic Communication: What Healthcare Professionals ...
Upcoming New 2025 HIPAA Changes and Beyond
HIPAA and the New Rules Regarding Reproductive Health Care
Prepare for the 2025 ICD-10-CM Code Updates
21 CFR Part 11 Electronic Records and Signatures FDA Compliance
USDA Final Genetically Modified Organism (GMO) Label Rule
Chronic Care Management What do you need to know to Design and Implement Succ...
Master CMS Medicare PECOS 2.0: New Enrollment and Validation Portal 2024
Corrective and Preventive Action (CAPA): Our Most Important Quality Process
G2211 and New 2024 Billing Opportunities
Understand and Apply ISO New Climate Change Requirements
Navigating Most Problematic CMS Standards - Hospital Restraint and Seclusion
DEI at the Hospital - Addressing Bias in Medical Staff Credentialing and Peer...
2024 HIPAA Compliance Training Guide to the Compliance Officers
Medicare and Medicaid Managed Care Enrollments in 2024
Dispelling HIPAA Myths: Texting, Emailing, and BYOD Best Practices
Medical Record Chapter: Meeting the CMS Hospital CoPs and Access Requirements
Grievances and Complaints 2024 Compliance with the CMS CoPs, Joint Commission...
The 2024 Prior Authorization Process For Medical Providers
Protecting Patient Privacy: Navigating HIPAA in Digital Landscapes
HIPAA Guidelines and Electronic Communication: What Healthcare Professionals ...
Ad

Recently uploaded (20)

PPTX
Importance of Immediate Response (1).pptx
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPTX
Basics of pharmacology (Pharmacology I).pptx
PPTX
Current Treatment Of Heart Failure By Dr Masood Ahmed
PPTX
ABG advance Arterial Blood Gases Analysis
PDF
Selvita_Development-Strategy-2022-2025.pdf
PPTX
different types of Gait in orthopaedic injuries
PPTX
Immunity....(shweta).................pptx
PDF
A Brief Introduction About Malke Heiman
PPTX
CBT FOR OCD TREATMENT WITHOUT MEDICATION
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PPTX
community services team project 2(4).pptx
PPTX
Nursing Care Aspects for High Risk newborn.pptx
PPTX
BLS, BCLS Module-A life saving procedure
PDF
Dermatology diseases Index August 2025.pdf
PPTX
Bronchial_Asthma_in_acute_exacerbation_.pptx
PPTX
AI_in_Pharmaceutical_Technology_Presentation.pptx
PPTX
Trichuris trichiura infection
PPTX
1. Drug Distribution System.pptt b pharmacy
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Importance of Immediate Response (1).pptx
Adrenergic drugs (sympathomimetics ).ppt
Basics of pharmacology (Pharmacology I).pptx
Current Treatment Of Heart Failure By Dr Masood Ahmed
ABG advance Arterial Blood Gases Analysis
Selvita_Development-Strategy-2022-2025.pdf
different types of Gait in orthopaedic injuries
Immunity....(shweta).................pptx
A Brief Introduction About Malke Heiman
CBT FOR OCD TREATMENT WITHOUT MEDICATION
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
community services team project 2(4).pptx
Nursing Care Aspects for High Risk newborn.pptx
BLS, BCLS Module-A life saving procedure
Dermatology diseases Index August 2025.pdf
Bronchial_Asthma_in_acute_exacerbation_.pptx
AI_in_Pharmaceutical_Technology_Presentation.pptx
Trichuris trichiura infection
1. Drug Distribution System.pptt b pharmacy
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING

FDA Best Audit Practices – Get Ready For The Inspection That Is Coming

  • 1. Live Webinar on FDA Inspection Readiness – Preparing for an Inspection Name of the Presenter. Charles H Paul, President C. H. Paul Consulting, Inc.
  • 2. Topics 2 ◼ The mechanics of the readiness process, auditing – who gets audited, frequency of audits, and the inspection process explained ◼ Types of inspections and their implications ◼ The heart of compliance – doing the right things right ◼ Selecting your subject matter experts ◼ Training your SME’s – what do they need to know and how do you train ◼ Inspection preparedness – what to expect and how to prepare ◼ The readiness inspection from the auditor’s perspective ◼ Responding/interacting with the inspection team – inspection behavior – how to act – what to say and what not to say
  • 3. Who does the FDA Inspect? ◼ Federal Food, Drug, and Cosmetics (FD&C) Act, domestic drug establishments, and Class II and Class III device manufacturers inspected every two years ◼ Foreign manufacturers ◼ Inspections conducted based on risk ◼ Higher-risk products more likely to be audited ◼ Facilities having historically significant violations ◼ Inspection focus  Quality and Product Safety  Facility  Process  Data 3
  • 4. Purpose of Inspections 4 • Compliance with FDA regulations • Product development • Quality System (QS) and manufacturing practices • Controls are in-place and they are effective • Recalls, enforcement actions, complaints, significant adverse event reports, surveillance • Ensure consumer protection
  • 5. Types of Inspections 5 ◼ Pre-Approval Inspections (PAI Post-Approval Inspections ◼ Surveillance Inspections ◼ For-Cause or Triggered Inspections ◼ Compliance Follow-Up Inspections ◼ Foreign Inspections ◼ Focused Inspections ◼ Risk-Based Inspections ◼ Follow-Up or Recurrent Inspections ◼ Adverse Event Inspections ◼ Import Inspections ◼ Bioequivalence and Bioavailability Inspections
  • 6. Types of Inspections ◼ Pre-Approval Inspections ◼ Post Approval Audit Inspections ◼ Drug Manufacturing Inspections 6
  • 7. Pre-Approval Inspections 7 ◼ FDA approves New Drug Applications, Abbreviated New Drug Applications, Biologic Licensing Applications ◼ Assure that controls for manufacture, processing, packing, and testing are adequate ◼ Pre-approval inspection performed to ensure that manufacturer can manufacture the drug.
  • 8. Post Approval Audit Inspections 8 ◼ Designed to audit for changes in the production and control practices that occur after approval ◼ Post Approval Audit Inspections confirm that commitments have been completed or are underway
  • 9. Drug Manufacturing Inspections 9 To determine whether inspected firms are operating in compliance with applicable cGMP requirements
  • 10. Best Practices – “Do the right Things Right” 10 ◼ Preparation • Have adequately trained staff with relevant expertise and accountability. • Obtain upper management support • Utilize and value independent regulatory compliance and quality assurance teams • Ensure the commitments made from previous inspections have been implemented • Understand your potential quality data sources so information can be quickly and easily sourced as required • Implement and assess an effective quality system • Ensure there is a designated company Inspection Team • Ensure all proper documentation and records are up-to-date • Maintain effective Management Review and CAPA systems. • Identify true root causes of issues using appropriate problem-solving tools. • Understand when a product, or quality issue is significant. • Have defined metric systems to monitor your quality system in order to identify trends, gaps, and opportunities
  • 11. Inspection Process Overview 11 ❑ Alert system activated ❑ Company Inspection Team members assemble ❑ FDA provides the company with Form 482 ❑ FDA will explain why they are at your site ❑ FDA provided with a facility tour ❑ FDA inspection team, will request the documents they need ❑ FDA will conduct the Exit Inspection Meeting. ❑ FDA findings are reviewed
  • 12. Post Inspection • Date of inspection • Inspection team members • Reasons for response • Response to each cited deficiency • Description of preventive and corrective action • Items still in dispute 12
  • 13. Post Inspection 13 ◼ If the inspection has an Official Action Indicated classification, FDA send a warning letter ◼ Company will need to reply ◼ FDA conducts a follow-up inspection ◼ FDA may issue a close-out letter
  • 14. Why are SME’s Indispensable to the Organization? 14 ◼ Expertise in Specific Areas ◼ Demonstrating Compliance ◼ Preparing Documentation ◼ Training and Coaching Staff ◼ Addressing Non-Compliance Issues ◼ Facilitating Communication ◼ Ensuring Ongoing Compliance
  • 15. Who are SMEs? 15 ◼ Quality Assurance (QA) and Quality Control (QC) Experts ◼ Regulatory Affairs Specialists ◼ Manufacturing and Process Engineers ◼ Microbiologists and Chemists ◼ Clinical Research Professionals ◼ Pharmacovigilance Experts ◼ Labeling and Packaging Specialists ◼ Validation Experts ◼ Food Safety and HACCP Experts ◼ Clinical Laboratory Directors ◼ Environmental Health and Safety Specialists ◼ Documentation and Records Management Experts
  • 16. Why is Proper SME Selection Important to the FDA Inspection? 44 ◼ Accuracy and Credibility ◼ Regulatory Understanding ◼ Effective Communication ◼ Smooth Inspection Process ◼ Confidence and Professionalism ◼ Problem-Solving Abilities ◼ Representation of Expertise ◼ Mitigating Risks ◼ Resource Efficiency ◼ Long-Term Impact ◼ Employee Morale ◼ Organizational Preparedness
  • 17. Selecting SMEs 17 ◼ Identify Relevant Areas ◼ Define SME Criteria ◼ Cross-Functional Representation ◼ Regulatory Knowledge ◼ Communication Skills ◼ Experience with Inspections ◼ Problem-Solving Abilities ◼ Preparation and Training ◼ Calm Under Pressure ◼ Collaborative Attitude ◼ Post-Inspection Feedback
  • 18. Preparing SME’s 18 ◼ Provide In-Depth Regulatory Training ◼ Review Inspection Process and Expectations ◼ Mock Inspection Workshops ◼ Communication Skills Training ◼ Prepare Documentation ◼ Familiarize with Facility Layout ◼ Prepare for Questions ◼ Confidence Building ◼ Team Collaboration ◼ Role-Playing Scenarios ◼ Post-Preparation Feedback
  • 19. Doing the Right Thing ◼ Always be professional ◼ Be dressed properly – neat and clean ◼ Follow all company cleanliness, movement, and dressing requirements ◼ Be courteous and polite at all times ◼ Correct all errors and miscommunications when discovered as soon as possible 19
  • 20. What a Successful FDA Audit Looks Like 20 ◼ Compliance with Regulations ◼ Public Health and Safety ◼ Market Confidence ◼ Continued Market Access ◼ Operational Improvements ◼ Reduced Legal and Financial Risk ◼ Enhanced Consumer Trust ◼ Facilitates Innovations ◼ Employee Morale and Engagement ◼ Educational Opportunity
  • 21. Tips for Doing it Right 21 ◼ Understand the Scope and Standards ◼ Maintain Compliance at All Times ◼ Conduct Regular Internal Audits ◼ Prepare Your Team ◼ Organize Documentation ◼ Review Past Inspections ◼ Mock Inspections ◼ Improve Communication Skills ◼ Ensure Facility Readiness ◼ Stay Informed About Industry Changes ◼ Legal and Expert Consultation ◼ Handle Issues Professionally
  • 22. Review 22 ◼ Always be prepared by doing the right things right ◼ Always maintain a compliant GMP environment ◼ Have effective and accessible compliance documentation ◼ Have a plan for how you will manage your inspection ◼ Be professional during an inspection ◼ Demonstrate proper body language ◼ Be timely in providing the documents and samples requested ◼ Control the flow of communication ◼ Properly answer questions ◼ Respond to findings thoroughly and in a timely manner